Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. I. Stankovic, Department of Cardiology, Clinical Hospital Centre Zemun and Faculty of Medicine, University of Belgrade, Serbia
“I would say that, right now, there is a hope that there will be a role for cardiac imaging in cardiac resynchronization therapy (CRT) in the near future and, thankfully, there is ongoing research.
In the beginning, we were overly enthusiastic but this was dampened by disappointing results from two major trials. I would say that, now, we are cautiously optimistic and it’s great to see that there is ongoing research, some presented at EuroEcho–Imaging 2016.
This is great because people were disappointed about the results of the PROSPECT trial in 2009,1 which indicated that there were no echocardiographic parameters that could help improve patient selection for CRT. There was subsequently a huge decline in publications on the topic. This was followed in 2013 by the EchoCRT trial,2 which showed that CRT was not beneficial in heart failure with a narrow QRS complex and may even increase mortality.
Since then, the whole concept has changed and novel parameters have emerged. What we need now is some hard evidence from new randomized trials to support these parameters. However, many people think that it would be an adventure to undertake such trials, and no-one is daring to start.
In terms of imaging techniques, echocardiography is, for me, number one for patient selection and, possibly, optimization in CRT. Magnetic resonance imaging should be used for assessing extent of myocardial scar. While nuclear techniques may be useful, they involve exposure to radiation.”
© 2017 European Society of Cardiology. All rights reserved